AZTR
$0.16
Market ClosedAs of Mar 17, 8:00 PM UTC
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
Wall Street Set to Open Higher Monday as Investors Look Ahead to a Week of Earnings Reports
US stocks look set to open higher in Monday's trading session ahead of a raft of earnings coming out
Why Is Azitra (AZTR) Stock Soaring Today
AZTR: Azitra Soars After First Patient Dosed in FDA Fast Track Trial
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%
Sector Update: Health Care Stocks Advance Wednesday Afternoon
Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Heal